Diametric Capital, LP - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 48 filers reported holding ETON PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Diametric Capital, LP ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$363,000
-13.6%
49,536
-4.1%
0.28%
-16.8%
Q4 2020$420,000
+70.7%
51,633
+65.8%
0.33%
+82.5%
Q3 2020$246,000
-80.4%
31,149
-86.4%
0.18%
-81.0%
Q2 2020$1,253,000
-32.4%
229,819
-49.2%
0.96%
-57.3%
Q1 2020$1,854,000
+80.0%
452,103
+177.3%
2.25%
+164.8%
Q3 2019$1,030,000
-9.7%
163,033
+12.8%
0.85%
+17.3%
Q2 2019$1,141,000
+17.0%
144,493
+18.6%
0.72%
-5.4%
Q1 2019$975,000
+170.1%
121,873
+106.6%
0.76%
+174.2%
Q4 2018$361,00059,0020.28%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Opaleye Management Inc. 2,430,270$10,134,2263.30%
Westside Investment Management, Inc. 528,310$2,203,0600.63%
Acuitas Investments, LLC 219,000$913,2300.54%
EAM Investors, LLC 256,623$1,070,1180.21%
Parkman Healthcare Partners LLC 165,000$688,0500.13%
ESSEX INVESTMENT MANAGEMENT CO LLC 110,016$458,7670.08%
PARADIGM CAPITAL MANAGEMENT INC/NY 300,000$1,251,0000.07%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 271,462$1,131,9970.03%
Quantum Private Wealth, LLC 11,500$47,9550.02%
CHICAGO TRUST Co NA 16,700$69,6390.02%
View complete list of ETON PHARMACEUTICALS INC shareholders